[Efficacy and safety of venetoclax combined with hypomethylating agents in the treatment of 83 patients with higher-risk myelodysplastic syndromes]. [PDF]
Liu L +6 more
europepmc +1 more source
[Clinical efficacy of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome-evolved acute myeloid leukemia]. [PDF]
Chen SL +11 more
europepmc +1 more source
[Efficacy and safety analysis of venetoclax combined with hypomethylating agents for the treatment of higher-risk myelodysplastic syndromes in the real world]. [PDF]
Gao QY +8 more
europepmc +1 more source
[Efficacy and safety analysis of hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia in low-risk myelodysplastic syndromes patients]. [PDF]
Lyu Y, Lin ZH, Yang L, Liu H.
europepmc +1 more source
[Analysis of the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome with blastomycosis and survival comparison of different subtypes after the WHO 2022 reclassification]. [PDF]
Wang H +12 more
europepmc +1 more source
[How I diagnose and treat chronic myelomonocytic leukemia]. [PDF]
Xiao ZJ.
europepmc +1 more source
[VEXAS syndrome mimicking relapsing polychondritis: A case report]. [PDF]
Dong Q, He J, Jia Y, Yao H, Zhang X.
europepmc +1 more source
[CAR-T cell therapy bridging to allogeneic hematopoietic stem cell transplantation for diffuse large B-cell Richter syndrome: a case report and literature review]. [PDF]
Wang Y +5 more
europepmc +1 more source
[Clonal evolution of myelodysplastic syndrome]. [PDF]
Luo BQ, Dong F, Ema MXF.
europepmc +1 more source
[Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)]. [PDF]
Chinese Society of Hematology +1 more
europepmc +1 more source

